18F-FDG PET for semiquantitative evaluation of acute allograft rejection and immunosuppressive therapy efficacy in rat models of liver transplantation

J Nucl Med. 2009 May;50(5):827-30. doi: 10.2967/jnumed.108.058925. Epub 2009 Apr 16.

Abstract

Acute allograft rejection remains a major complication after liver transplantation. We report a semiquantitative imaging method of detecting acute allograft rejection with (18)F-FDG PET.

Methods: Syngeneic and allogeneic transplanted rats, with or without immunosuppressive treatment, were subjected to serial PET. Autoradiography of the liver was conducted in both the syngeneic and the allogeneic rats.

Results: A significant increment of (18)F-FDG accumulation in liver allografts was observed by PET on day 2. The (18)F-FDG signal was concentrated in the area where inflammatory cells around the vessels were detected by autoradiography. Allotransplanted rats treated with an immunosuppressive agent displayed a marked decrease in hepatic (18)F-FDG uptake, compared with allotransplanted rats that were not treated.

Conclusion: (18)F-FDG PET may be a valid method for facilitating the development of protocols to diagnose graft rejection and to monitor the efficacy of immunosuppressive therapy.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Fluorodeoxyglucose F18*
  • Graft Rejection / diagnostic imaging*
  • Graft Rejection / etiology
  • Graft Rejection / prevention & control*
  • Humans
  • Image Interpretation, Computer-Assisted / methods
  • Immunosuppressive Agents / administration & dosage*
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / diagnostic imaging*
  • Male
  • Positron-Emission Tomography / methods*
  • Prognosis
  • Radiopharmaceuticals
  • Rats
  • Rats, Inbred Lew
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18